Gastroparesis Treatment Companies

Evoke Pharma's Phase 3 Trial Success drug Ghrelin agonist, lonazepide, shows promise in a recent trial, potentially offering relief for Gastroparesis patients. This news sends Evoke's stock soaring and reignites hope for new treatment options.

Sumitomo Dainippon Pharma Partners with Medtronic collaboration combines Medtronic's expertise in gastric electrical stimulation (GES) with Sumitomo Dainippon's innovative drug pipeline, aiming to develop comprehensive treatment approaches for Gastroparesis.

GIThera and GastroIntestinal Health are developing AI algorithms to improve Gastroparesis diagnosis and personalize treatment plans based on individual patient data.

List of Gastroparesis Treatment Key Companies in the Market

• Medtronic


• Kimberly-Clark Corporation


• Abbott Laboratories


• Salix Pharmaceuticals, Inc


• Boston Scientific Corporation


• C. R. Bard, Inc


• Janssen Global Services LLC


• Cardinal Health, Inc.


• Alfa Wassermann SPA


• Evoke Pharma


• Rhythm Pharmaceuticals, Inc